Skip to main content
BLLN
NASDAQ Life Sciences

BillionToOne Beats on Q3 Revenue, Lifts 2026 Outlook to $460-470M

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$119.49
Mkt Cap
$5.374B
52W Low
$61.96
52W High
$150.44
52W Position info
93% above low
Off High info
21% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

BLLN sits 93% above its 52-week low of $61.96.

Summary

BillionToOne delivered Q3 2026 revenue of $123.0 million, up 47% from $83.5 million a year ago, with oncology testing revenue nearly doubling to $17.1 million. Net income jumped to $17.4 million, or $0.32 per diluted share, versus $1.5 million a year earlier, and gross margin held at 71%. The company raised full-year 2026 revenue guidance to $460-470 million from $450-465 million, implying 51-54% growth, and said it expects profitability similar to current levels even with heavy investment. Management also flagged the December 15, 2026 commercial launch of Northstar Clear, a tissue-free MRD test for all solid tumors, extending the oncology franchise. This is the first quarterly report since the Q2 print showed $109.4 million in revenue and a swing to profitability, so the sequential acceleration and guidance raise reinforce the growth story.

At the time of this announcement, BLLN was trading at $119.49 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.4B. The 52-week trading range was $61.96 to $150.44. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

BLLN - Latest Insights

BLLN
Nov 18, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $91.54
Real-time Price: $90.20 info
Change: -$1.34 (-1%) info
Market Cap: $4.309B info
BLLN
Nov 18, 2026, 9:38 AM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $87.83
Real-time Price: $90.20 info
Change: +$2.37 (+3%) info
Market Cap: $4.309B info
BLLN
Nov 04, 2026, 4:47 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $113.00
Real-time Price: $90.20 info
Change: -$22.80 (-20%) info
Market Cap: $4.309B info
BLLN
Oct 07, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $99.87
Real-time Price: $90.20 info
Change: -$9.67 (-10%) info
Market Cap: $4.309B info
BLLN
Aug 05, 2026, 4:42 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $113.35
Real-time Price: $90.20 info
Change: -$23.15 (-20%) info
Market Cap: $4.309B info